Various embodiments concern approaches to reducing the optical interference experienced by interferometric sensing systems, for example, during a biochemical test in which analyte molecules in a sample bind to a probe.
Diagnostic tests based on binding events between analyte molecules and analyte-binding molecules are widely used in medical, veterinary, agricultural, and research applications. These diagnostic tests can be employed to detect whether analyte molecules are present in a sample, the amount of analyte molecules in a sample, or the rate of binding of analyte molecules to the analyte-binding molecules. Together, an analyte-binding molecule and its corresponding analyte molecule form an analyte-anti-analyte binding pair (or simply “binding pair”). Examples of binding pairs include complementary strands of nucleic acids, antigen-antibody pairs, and receptor-receptor binding agents. The analyte can be either member of the binding pair, and the anti-analyte can be the other member of the binding pair.
Historically, diagnostic tests have employed a solid, planar surface having analyte-binding molecules immobilized thereon. Analyte molecules in a sample will bind to these analyte-binding molecules with high affinity in a defined detection zone. In this type of assay, known as a “solid-phase assay,” the solid, planar surface is exposed to the sample under conditions that promote binding of the analyte molecules to the analyte-binding molecules. Generally, the binding events are detected directly by measuring changes in mass, reflectivity, thickness, color, or another characteristic indicative of a binding event. For example, when an analyte molecule is labeled with a chromophore, fluorescent label, or radiolabel, the binding events are detectable based on how much, if any, label can be detected within the detection zone. Alternatively, the analyte molecule could be labeled after it has bound to an analyte-binding molecule within the detection zone.
U.S. Pat. No. 5,804,453 discloses a method of determining the concentration of a substance in a sample solution, using an optical fiber having a reagent (i.e., a capturing molecule) coated directly at its distal end to which the substance binds. The distal end is then immersed into the sample containing the analyte. Binding of the analyte to the reagent layer generates an interference pattern and is detected by a spectrometer.
U.S. Pat. No. 7,394,547 discloses a biosensor that includes a first optically transparent element that is mechanical attached to an optical fiber tip with an air gap between them, and a second optically transparent element that serves as the interference layer with a thickness greater than 50 nanometers (nm) is then attached to the distal end of the first optically transparent element. The biolayer is formed on the peripheral surface of the second optically transparent element. An additional reflective surface layer with a thickness between 5-50 nm and a refractive index greater than 1.8 is coated between the interference layer and the first element. The principle of detecting an analyte in a sample based on the changes of spectral interference is described in this reference, which is incorporated herein by reference.
U.S. Pat. No. 7,319,525 discloses a different configuration in which a section of an optical fiber is mechanically attached to a tip connector consisting of one or more optical fibers with an air gap between the proximal end of the optical fiber section and the tip connector. The interference layer and then the biolayer are built on the distal surface of the optical fiber section.
Although prior art provides functionality in utilizing biosensors based on thin-film interferometers, there exists a need for improvements in the performance of these interferometers.
Embodiments are illustrated by way of example and not limitation in the drawings. While the drawings depict various embodiments for the purpose of illustration, those skilled in the art will recognize that alternative embodiments may be employed without departing from the principles of the technology. Accordingly, while specific embodiments are shown in the drawings, the technology is amenable to various modifications.
The term “about” means within ±10% of the recited value.
The term “analyte-binding molecule” refers to any molecule capable of participating in a binding reaction with an analyte molecule. Examples of analyte-binding molecules include, but are not limited to, (i) antigen molecules, for use in detecting the presence of antibodies specific against that antigen; (ii) antibody molecules, for use in detecting the presence of antigens; (iii) protein molecules, for use in detecting the presence of a binding partner for that protein; (iv) ligands, for use in detecting the presence of a binding partner; and (v) single-stranded nucleic acid molecules, for use in detecting the presence of nucleic acid molecules.
The term “interferometric sensor” refers to any sensing apparatus upon which a biolayer is formed to produce an interference pattern. One example of an interferometric sensor is a probe designed to be suspended in a solution containing the sample having the analyte molecules. Another example of an interferometric sensor is a slide with a planar surface upon which a biolayer can be formed over the course of a biochemical test.
The term “probe” refers to a monolithic substrate having an aspect ratio (length-to-width) of at least 2 to 1 with a thin-film layer coated on the sensing side.
The term “monolithic substrate” refers to a solid piece of material having a uniform composition, such as glass, quartz, or plastic, with one refractive index.
The term “waveguide” refers to a device designed to confine and direct the propagation of electromagnetic waves as light. One example of a waveguide is a flexible, transparent fiber made by drawing glass, plastic, or another transparent material to a small diameter (e.g., roughly that of a human hair). These waveguides are commonly called “optical fibers.” Another example of a waveguide is a metal tube for channeling ultrahigh-frequency waves. Waveguides could also take the form of ducts or coaxial cables.
Several entities have developed interferometric sensing systems (also called “interferometers” or simply “systems”) designed to conduct biochemical tests.
The light source 102 may emit light that is guided toward the probe 108 by the waveguide 106. For example, the light source 102 may be a light-emitting diode (LED) that is configured to produce light over a range of at least 50 nanometers (nm), 100 nm, or 150 nm within a given spectrum (e.g., 400 nm or less to 700 nm or greater). Alternatively, the interferometer 100 may employ a plurality of light sources having different characteristic wavelengths, such as LEDs designed to emit light at different wavelengths in the visible range. The same function could be achieved by a single light source with suitable filters for directing light with different wavelengths onto the probe 108.
The detector 104 is preferably a spectrometer, such as an Ocean Optics USB4000, that is capable of recording the spectrum of interfering light received from the probe 108. Alternatively, if the light source 102 operates to direct different wavelengths onto the probe 108, then the detector 104 can be a simple photodetector capable of recording intensity at each wavelength. In another embodiment, the detector 104 can include multiple filters that permit detection of intensity at each of multiple wavelengths.
The waveguide 106 can be configured to transport light emitted by the light source 102 to the probe 108, and then transport light reflected by surfaces within the probe 108 to the detector 104. In some embodiments the waveguide 106 is a bundle of optical fibers (e.g., single-mode fiber optic cables), while in other embodiments the waveguide 106 is a multi-mode fiber optic cable.
As shown in
The interference layer normally includes multiple layers that are combined in such a manner to improve the detectability of the interference pattern. Here, for example, the interference layer comprises a tantalum pentoxide (Ta2O5) layer 116 and a silicon dioxide (SiO2) layer 118. The tantalum pentoxide layer 116 may be thin (e.g., on the order of 10-40 nm) since its main purpose is to improve reflectivity at the proximal surface of the interference layer. Meanwhile, the silicon dioxide layer 118 may be comparatively thick (e.g., on the order of 650-900 nm) since its main purpose is to increase the distance between the first and second reflecting surfaces.
To perform a biochemical test, the probe 108 can be suspended in a microwell 110 (or simply “well”) that includes a sample 112. Analyte molecules 122 in the sample 112 will bind to the analyte-binding molecules 120 along the distal end of the probe 108 over the course of the biochemical test, and these binding events will result in an interference pattern that can be observed by the detector 104. The interferometer 100 can monitor the thickness of the biolayer formed along the distal end of the probe 108 by detecting shifts in a phase characteristic of the interference pattern.
As shown in
Unparallel surfaces along the coupling interface 124 can result in the generation of a high-frequency interference pattern as mentioned above. As an illustrative example, for white light in the visible portion of the electromagnetic spectrum, the high-frequency interference pattern tends to occur when the unparallel surfaces at the coupling interfaces are less than about two micrometers (μm) apart. As such, this problem tends to present itself only when the surfaces forming the coupling interface 124 are quite close to one another. The high-frequency interference pattern resulting from unparallel surfaces can add to the monitored interference pattern, causing inaccuracy when calculating the phase shift since the high-frequency interference pattern is roughly stationary while the monitored inference pattern shifts. Simply put, the monitored interference pattern has a smooth—and therefore consistent and predictable—form in comparison to the monitored interference in combination with the high-frequency interference pattern. The high-frequency interference pattern can degrade the monitored interference pattern as the magnitude may “jump” as shown in the rightmost plot in
Introduced here is an approach to mitigating (e.g., lessening or eliminating) the high-frequency interference pattern that is caused by uneven surfaces along the coupling interface formed between the waveguide and probe of an interferometric sensing system. Said another way, the approach is intended to reduce the high-frequency interference pattern caused by the interference when a waveguide—for example, in the form of an optical fiber—and a probe are directly coupled to one another. Note that the phrases “directly coupled” and “coupled with no air gap” may be used to refer to a scenario where the waveguide and probe physically contact one another along at least part of the respective surfaces or where the waveguide and probe are so close to one another that refraction in the gap established therebetween (e.g., generally no more than five um) does not meaningfully impact the light traveling toward the distal end of the probe or returning from the distal end of the probe. When the respective surfaces are pushed together along a coupling interface, there are generally contact points and non-contact points. Non-contact points may be due to the roughing of the surface of the waveguide, and therefore may be referred to as “voids” along the coupling interface. While these voids are generally not intended, these voids tend to exist due to the roughened surface being located along the coupling interface.
Specifically, the coupling surface of the waveguide can be treated, for example, with sandpaper, sandblasting, or acid etching, to create a frosted surface texture. In operation, the frosted surface scatters the light emitted through the waveguide, preventing the high-frequency interference pattern from occurring. The surface roughness parameter Ra may vary depending on the nature of the light emitted through the waveguide. However, for applications that use white light, it has been found that the preferred surface roughness parameter Ra is between about 0.5 μm and 10 μm.
Note that while embodiments of the interferometric sensing system may be described in the context of a waveguide with a frosted distal surface, a comparable approach may be employed to make the other coupling surface—namely, the proximal surface of the probe—frosted too. To prevent the high-frequency interference pattern, at least one of the surfaces forming the coupling interface may be roughened and frosted, though both surfaces could be roughened and frosted.
Moreover, embodiments of the interferometric sensing system may be described in the context of a probe designed to be suspended within a solution containing a sample for the purpose of illustration. However, those skilled in the art will recognize that these features are equally applicable to other sensing surfaces, such as planar surfaces (e.g., a slide) upon which a biolayer is formed by flowing a solution over the planar surface over the course of a biochemical test.
As shown in
The interference layer 204 is comprised of at least one transparent material that is coated on the distal surface of the monolithic substrate 202. These transparent material(s) are deposited on the distal surface of the monolithic substrate 202 in the form of thin films ranging in thickness from fractions of a nanometer (e.g., a monolayer) to several micrometers. The interference layer 204 may have a thickness of at least 500 nm, 700 nm, or 900 nm. An exemplary thickness is between 500-5,000 nm (and preferably 800-1,200 nm). Here, for example, the interference layer 204 has a thickness of approximately 900-1,000 nm, or 940 nm.
In contrast to conventional probes, the interference layer 204 has a substantially similar refractive index as the biolayer. This ensures that the reflection from the distal end of the probe 200 is predominantly due to the analyte molecules 208 rather than the interface between the interference layer 204 and the analyte-binding molecules 206. Generally, the biolayer has a refractive index of approximately 1.36, though this may vary depending on the type of analyte-binding molecules (and thus analyte molecules) along the distal end of the probe 200.
In some embodiments the interference layer 204 is comprised of magnesium fluoride (MgF2), while in other embodiments the interference layer 204 is comprised of potassium fluoride (KF), lithium fluoride (LiF), sodium fluoride (NaF), lithium calcium aluminum fluoride (LiCaAlF6), strontium fluoride (SrF2), aluminum fluoride (AlF3), sulfur hexafluoride (SF6), etc. Magnesium fluoride has a refractive index of 1.38, which is substantially identical to the refractive index of the biolayer formed along the distal end of the probe 200. For comparison, the interference layer of conventional probes is normally comprised of silicon dioxide, and the refractive index of silicon dioxide is approximately 1.4-1.5 in the visible range. Because the interference layer 204 and biolayer have similar refractive indexes, light will experience minimal scattering as it travels from the interference layer 204 into the biolayer and then returns from the biolayer into the interference layer 204.
During a biochemical test, the probe 200 can be suspended within a cavity (e.g., a well) that includes a sample. Over the course of the biochemical test, a biolayer will form along the distal end of the probe 200 as analyte molecules 208 bind to the analyte-binding molecules 206. When light is shone on the probe 200, the proximal surface of the interference layer 204 may act as a first reflecting surface and the distal surface of the biolayer may act as a second reflecting surface. The presence, concentration, or binding rate of analyte molecules 208 to the probe 200 can be estimated based on the interference of beams of light reflected by these two reflecting surfaces. As analyte molecules 208 attach to (or detach from) the analyte-binding molecules 206, the distance between the first and second reflecting surfaces will change. Because the dimensions of all other components in the probe 200 remain the same, the interference pattern formed by the light reflected by the first and second reflecting surfaces is phase shifted in accordance with changes in biolayer thickness due to binding events.
In operation, an incident light signal 210 emitted by a light source is transported through the monolithic substrate 202 toward the biolayer. Within the probe 200, light will be reflected at the first reflecting surface resulting in a first reflected light signal 212. Light will also be reflected at the second reflecting surface resulting in a second reflected light signal 214. The second reflecting surface initially corresponds to the interface between the analyte-binding molecules 206 and the sample in which the probe 200 is immersed. As binding occurs during the biochemical test, the second reflecting surface becomes the interface between the analyte molecules 208 and the sample.
The first and second reflected light signals 212, 214 form a spectral interference pattern, as shown in
Referring to
Directly coupling the distal end of the waveguide (not shown) to the proximal end of the probe 200 accomplishes the second and third of these goals, namely, by preventing the inadvertent scattering of light leaving those surfaces. Note, however, that directly coupling those surfaces to one another can result in other problems as discussed above.
The adhesion layer 310 may comprise a material that promotes adhesion of the analyte-binding molecules 306. One example of such a material is silicon dioxide. The adhesion layer 310 is generally very thin in comparison to the interference layer 304, so its impact on light traveling toward, or returning from, the biolayer will be minimal. For example, the adhesion layer 310 may have a thickness of approximately 3-10 nm, while the interference layer 304 may have a thickness of approximately 800-1,000 nm. The biolayer formed by the analyte-binding molecules 306 and analyte molecules 308 will normally have a thickness of several nm. Much like probe 200 of
As mentioned above, these features are equally applicable to sensing surfaces having other forms. One example of such a sensing surface is a slide (also referred to as a “chip”) with a planar surface upon which a biolayer is formed by flowing a solution over the planar surface over the course of a biochemical test. Several examples of planar surfaces are discussed below with reference to
Over the course of a biochemical test, analyte molecules 508 can bind to analyte-binding molecules 506 that have been secured along the upper surface of the interference layer 504 to form a biolayer. To establish the thickness of the biolayer, light can be shone at the upper surface of the slide 500 as shown in
Here, however, the incident light signal 610 is shown at the lower surface of the slide 600. In operation, the incident light signal 610 is transported through the substrate 602 toward the biolayer. Within the slide 600, light will be reflected at a first reflecting surface resulting in a first reflected light signal 612. The first reflecting surface may be representative of the interface between the interference layer 604 and substrate 602. Light will also be reflected at a second reflecting surface resulting in a second reflected light signal 614. The second reflecting surface may be representative of the interface between the biolayer and ambient media 616. As discussed above, the first and second reflected light signals 612, 614 form a spectral interference pattern that can be analyzed to establish the thickness of the biolayer.
While not shown in
The manufacturer can then treat the distal end of the waveguide such that its surface roughness falls within a predetermined range (step 702) that is defined by a first surface roughness parameter R1 and a second surface roughness parameter R2 that is higher than the first surface roughness parameter R1. This can occur in various ways.
For example, the manufacturer may roughen the distal end of the waveguide with a coated abrasive or another rough surface. At a high level, a coated abrasive is a product that includes a layer of abrasive grain attached to a substrate such as paper, cloth, fiber, or combinations thereof. One example of a coated abrasive is sandpaper, which generally consists of one or more sheets of paper, cloth, or another substrate with abrasive material—like sand—adhered to one side. Coated abrasives are available in a variety of forms, including sheets, disks, rolls, and belts. Commonly used abrasive grains include sand, aluminum oxide, zirconium, ceramic, silicon carbide, and garnet. To form the abrasive grains, crude grains are normally crushed and then separated by size using calibrated screens. The sizes (also called “grits”) can range from P12 (very coarse) to P2500 (very fine). After the abrasive grains have been separated by size, the abrasive grains can be attached to a substrate using various bonding techniques. Because only slight roughening of the distal end of the waveguide is needed, larger grit number (and therefore, smaller abrasive grain size) is generally preferred. For example, the distal end of the waveguide may be roughened with a coated abrasive having a grit number higher than P400, P800, P1000, P1200, or P2000. Coated abrasives having a grit number of P400, P500, or P600 are generally called “extra fine” coated abrasives, coated abrasives having a grit number of P800, P1000, or P1200 are generally called “super fine” coated abrasives, and coated abrasives having a grit number of P1500, P2000, or P2500 are generally called “ultra fine” coated abrasives. Depending on the desired roughness, the manufacturer may choose any suitable extra fine, super fine, or ultra fine coated adhesive. Note that these examples are provided solely for the purpose of illustration; in some embodiments, a coarser coated adhesive may be desirable.
As another example, the manufacturer may roughen the distal end of the waveguide via a sandblasting process. The term “sandblasting” is commonly used to refer to the process by which a surface—like the distal end of the waveguide—is roughened by impelling a stream of abrasive material against that surface using a fluid (e.g., water or air). Normally, sandblasting is performed under high pressure to roughen a smooth surface while also removing any excess particles (e.g., parts of the surface that are “blasted” off), though sandblasting could also be used to smoothen rough surfaces. Various materials could be used as the abrasive material, including sand, aluminum oxide, silicon carbide, garnet, and walnut husks. The size of the abrasive material may be selected to slightly roughen the distal end of the waveguide (e.g., to obtain surface roughness between 0.5 μm and 10 μm).
As another example, the manufacturer may roughen the distal end of the waveguide via an acid etching process. The term “acid etching” is commonly used to refer to the process by which a surface—like the distal end of the waveguide—is treated with an acid (e.g., hydrofluoric acid) to achieve a slight roughening, leading to a frosted appearance. Normally, a resist is applied to the surface before it is dipped into the acid. Once in the acid, the portion of the surface that is not covered with resist is etched away, changing its appearance and structure. The manufacturer could apply resist along the sides of the waveguide to ensure that only the surface along the distal end is etched, or the manufacturer may not apply resist at all since the sides of the waveguide may be covered (e.g., by a protective sheath).
At a high level, the distal end of the waveguide is roughened to create a frosted surface texture, regardless of the approach employed by the manufacturer. As mentioned above, in operation, the frosted surface texture scatters light emitted through the distal end of the waveguide.
The manufacturer can then acquire a monolithic substrate (step 703). For example, the manufacturer may select the monolithic substrate from amongst multiple monolithic substrates designed for different biochemical tests, analyte-binding molecules, etc. The preferred refractive index of the monolithic substrate may be higher than 1.3, 1.5, 1.8, or 2.0. Accordingly, the monolithic substrate acquired by the manufacturer may comprise a high-refractive-index material, such as glass (refractive index of 2.0), or a low-refractive-index material, such as quartz (refractive index of 1.46) or plastic (refractive index of 1.32-1.49). As discussed above, in some embodiments the monolithic substrate has a columnar form (e.g., monolithic substrates 202, 302 of
Note that, in some embodiments, the proximal end of the monolithic substrate to which the distal end of the waveguide is to be connected may also be treated. Said another way, the proximal end of the monolithic substrate could be treated such that its surface roughness falls within a predetermined range. Generally, the proximal end of the monolithic substrate is treated similarly to the distal end of the waveguide, and therefore, the predetermined range may be defined by the same surface roughness parameters, namely, R1 and R2, as the distal end of the waveguide.
Then, the manufacturer can deposit a transparent material on the surface of the monolithic substrate to form an interference layer (step 704). For example, the transparent material may be deposited onto the distal surface of the monolithic substrate in the form of a thin film ranging in thickness from fractions of a nanometer (e.g., a monolayer) to several micrometers. Normally, the interference layer has a thickness of at least 500 nm, 700 nm, or 900 nm. An exemplary thickness is between 500-5,000 nm (and preferably 800-1,200 nm).
In some embodiments, the manufacturer deposits another transparent material on the surface of the interference layer to form an adhesion layer (step 705). The adhesion layer may comprise a material that promotes adhesion of analyte-binding molecules. One example of such a material is silicon dioxide. The adhesion layer is generally very thin in comparison to the interference layer, so its impact on light traveling along the interferometric sensor will be minimal. For example, the adhesion layer may have a thickness of approximately 3-10 nm.
Thereafter, the manufacturer can secure analyte-binding molecules to the surface of the adhesion layer (step 706). As discussed above, a layer of analyte-binding molecules can be formed under conditions in which the surface of the interferometric sensor (e.g., the distal end of a probe, or the distal surface of a planar chip) is densely coated. This ensures that as analyte molecules bind to the analyte-binding molecules over the course of a biochemical test, these binding events result in a change in the thickness of the biolayer rather than filling in the layer of analyte-binding molecules. The layer of analyte-binding molecules can be a monolayer or a multi-layer matrix.
Thereafter, the manufacturer can optically couple the proximal end of the waveguide to the light source and detector (step 707). Similarly, the manufacturer can optically couple the distal end of the waveguide to the monolithic substrate (step 708), so as to form a roughly contiguous structure with no gap therebetween. As mentioned above, while small voids may occur along the interface between the waveguide and monolithic substrate due to roughening, these components may be coupled to one another such that the distal end of the waveguide contacts the proximal end of the monolithic substrate in at least one location.
Accordingly, the interferometric sensing system can include (i) a monolithic substrate that has first and second surfaces arranged substantially parallel to one another at opposite ends of the monolithic substrate, (ii) an interference layer that is coated on the second surface of the monolithic substrate, (iii) a layer of analyte-binding molecules that is coated on the interference layer, and (iv) a waveguide having a roughened surface that is coupled to the first surface of the monolithic substrate. In operation, a first interface between the monolithic substrate and the interference layer can act as a first reflecting surface when light is shone through the waveguide onto the monolithic substrate, and a second interface between a biolayer formed by analyte molecules in a sample binding to the analyte-binding molecules and a solution containing the sample can act as a second reflecting surface when the light is shone through the waveguide onto the monolithic substrate.
Unless contrary to physical possibility, it is envisioned that the steps described above may be performed in various sequences and combinations. For example, in embodiments where the monolithic substrate is disposable, step 704 may be performed each time that a biochemical test is performed. Accordingly, steps 701-707 may be performed by the manufacturer, while step 708 may be performed by the manufacturer or another entity or person. It is also envisioned that some steps described may not be performed at all. For example, the manufacturer may choose not to create an adhesion layer along the distal surface of the interference layer. In such embodiments, step 705 may not be performed, and therefore the analyte-binding molecules may be secured directly to the distal surface of the interference layer.
Additional steps may also be performed.
For example, the manufacturer may roughen the proximal end of the monolithic substrate similar to how the distal end of the waveguide is roughened in step 702, as discussed above. Note, however, that the proximal end of the monolithic substrate does not necessarily need to be roughened in the same manner as the distal end of the waveguide. For example, the distal end of the waveguide may be roughed via a sandblasting process, while the proximal end of the monolithic substrate may be roughened via an acid etching process. Similarly, the proximal end of the monolithic substrate does not necessarily need to be roughened to the same degree as the distal end of the waveguide. The proximal end of the monolithic substrate could be roughened more or less than the distal end of the waveguide.
As another example, the manufacturer may form a reflection layer on the surface of the monolithic substrate. As discussed above, the reflection layer may comprise a transparent material that has a higher refractive index than the monolithic substrate and the interference layer. Because of its location, this transparent material may be deposited onto the surface of the monolithic substrate before the interference layer is formed (i.e., before step 702 is performed). As another example, the manufacturer may cure the interference layer (e.g., using heat, air, radiation, etc.) before forming the adhesion layer. Similarly, the manufacturer may cure (i) the reflection layer before securing the adhesion layer thereto and/or (ii) the adhesion layer before securing the analyte-binding molecules thereto. As another example, the manufacturer may polish first and second surfaces of the monolithic substrate that are arranged substantially parallel to one another at opposite ends of the monolithic substrate. Polishing may be performed to improve adhesion of the interference layer to the monolithic substrate.
The foregoing description of various embodiments of the technology has been provided for the purposes of illustration and description. It is not intended to be exhaustive or to limit the claimed subject matter to the precise forms disclosed.
Many modifications and variations will be apparent to those skilled in the art. Embodiments were chosen and described in order to best describe the principles of the technology and its practical applications, thereby enabling others skilled in the relevant art to understand the claimed subject matter, the various embodiments, and the various modifications that are suited to the particular uses contemplated.
Number | Date | Country | Kind |
---|---|---|---|
202210413194.2 | Apr 2022 | CN | national |
This application is a continuation of International Application No. PCT/US2023/65913, filed on Apr. 18, 2023, which claims priority to U.S. Provisional Application No. 63/363,449, filed on Apr. 22, 2022, and Chinese Application No. 202210413194.2, filed on Apr. 19, 2022, each of which is incorporated by reference herein in its entirety.
Number | Date | Country | |
---|---|---|---|
63363449 | Apr 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2023/065913 | Apr 2023 | WO |
Child | 18917989 | US |